Oncolytic Virus Enlisted as a Helper to Hance DC Vaccine’s Anti-tumor Potency
Recently, a research paper titled “Oncolytic virus M1 functions as a bifunctional checkpoint inhibitor to enhance the antitumor activity of DC vaccine” was published in Cell Reports Medicine, a sub-journal of Cell.Read More…